Recruiting NA Tobacco Use

New treatment option for Tobacco Use

Official title Little Cigar Oxidants

ClinicalTrials.gov ID: NCT06310187

What this study is testing

What it's testing
Determine the effects of little cigars on human exposure to tobacco smoke oxidants. In a balanced randomized cross-over study design in cigarette smokers, subjects will be assigned to 3 exposure groups.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 21 to 65

You may be able to join if

  • Aged 21 - 65 years old
  • Daily cigarette smoker (\>= 1 cigarette per day);
  • Smoke regular, filtered cigarettes or machine rolled cigarettes with a filter
  • No current or past use of Little Cigars
  • All other forms of nicotine must be used \<6 days out of the past 30 days.

You likely can't join if

  • Women who are pregnant and/or nursing or trying to become pregnant
  • Unstable or significant medical condition in the past 3 months (e.g., recent heart attack or other serious heart condition, stroke, severe angina)
  • Respiratory diseases (e.g., exacerbations of asthma or Chronic Obstructive Pulmonary Disease (COPD), require oxygen, require oral prednisone), kidney...
  • Uncontrolled substance abuse or inpatient treatment for that condition in the past 6 months
  • Exhaled Carbon Monoxide (CO) measurement of \>= 17 parts per million
See the full eligibility criteria
Who can join
  • Aged 21 - 65 years old
  • Daily cigarette smoker (\>= 1 cigarette per day);
  • Smoke regular, filtered cigarettes or machine rolled cigarettes with a filter
  • No current or past use of Little Cigars
  • All other forms of nicotine must be used \<6 days out of the past 30 days.
  • Able to read and write in English
  • No serious cigarette smoking quit attempt or use of any FDA-approved smoking cessation medication in the prior 30 days
  • No plan to quitting smoking in the next 3 months
What rules you out
  • Women who are pregnant and/or nursing or trying to become pregnant
  • Unstable or significant medical condition in the past 3 months (e.g., recent heart attack or other serious heart condition, stroke, severe angina)
  • Respiratory diseases (e.g., exacerbations of asthma or Chronic Obstructive Pulmonary Disease (COPD), require oxygen, require oral prednisone), kidney (e.g., dialysis) or liver disease (e.g., cirrhosis), severe immune...
  • Uncontrolled substance abuse or inpatient treatment for that condition in the past 6 months
  • Exhaled Carbon Monoxide (CO) measurement of \>= 17 parts per million

The study team makes the final eligibility decision.

Where it's taking place

  • Hershey, Pennsylvania, United States

Compensation & support

Compensation mentioned.

ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.

Questions & answers

Do participants get paid in this trial?

This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 21 years to 65 years. The study team makes the final eligibility decision.

Where is this trial taking place?

Study sites include Hershey, Pennsylvania, United States. Enter your location above to see the nearest site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.